The BubR1 gene encodes for a mitotic regulator that ensures accurate segregation of chromosomes through its role in the mitotic checkpoint and the establishment of proper microtubule-kinetochore attachments. Germline mutations that reduce BubR1 abundance cause aneuploidy, shorten lifespan and induce premature ageing phenotypes and cancer in both humans and mice. A reduced BubR1 expression level is also a feature of chronological ageing, but whether this age-related decline has biological consequences is unknown. Using a transgenic approach in mice, we show that sustained high-level expression of BubR1 preserves genomic integrity and reduces tumorigenesis, even in the presence of genetic alterations that strongly promote aneuplodization and cancer, such as oncogenic Ras. We find that BubR1 overabundance exerts its protective effect by correcting mitotic checkpoint impairment and microtubule-kinetochore attachment defects. Furthermore, sustained high-level expression of BubR1 extends lifespan and delays age-related deterioration and aneuploidy in several tissues. Collectively, these data uncover a generalized function for BubR1 in counteracting defects that cause whole-chromosome instability and suggest that modulating BubR1 provides a unique opportunity to extend healthy lifespan.
cohesion rings that hold sister chromatids together 1 . BubR1 contributes to proper chromosome segregation not only through mitotic checkpoint activation but also by regulation of chromosome-spindle attachments 2, 3 . Mutant mice carrying BubR1 hypomorphic alleles (BubR1 H/H mice) that produce low amounts of the protein are prone to aneuploidy and develop various progeroid and age-related phenotypes, including short lifespan, growth retardation, cataracts, sarcopenia, subdermal fat loss, impaired wound healing and reduced dermal thickness 1, [4] [5] [6] . Mutations in BubR1 have been associated with mosaic variegated aneuploidy, a rare human syndrome characterized by aneuploidization, tumour predisposition and several progeroid traits, including short lifespan, growth and mental retardation, cataracts and facial dysmorphisms [7] [8] [9] . These data, together with the observation that BubR1 abundance declines with age in various mouse tissues 1, 4, 5 , led to the notion that BubR1 may contribute to chronological ageing.
We reasoned that if depletion of BubR1 with age contributes to ageing and age-related disorders, then increased expression of BubR1 might extend healthy lifespan. To test this hypothesis, we generated transgenic mice expressing BubR1 fused to a Flag tag under the control of the ubiquitous CAGGS promoter ( Fig. 1a ). As a marker for transgene expression, we co-expressed enhanced green fluorescent protein (EGFP) from an internal ribosome entry site. Two independent BubR1 transgenic lines were obtained, henceforth referred to as T7 and T23. Western blot analysis of a broad spectrum of tissues indicated that T7 and T23 mice expressed moderate and high amounts of Flag-BubR1, respectively ( Fig. 1b and Supplementary Fig. S1a-c) . Expression of Flag-BubR1 corrected all premature ageing phenotypes of BubR1 H/H mice ( Fig. 1c , and data not shown), confirming that the Flag-BubR1 protein was functional and adequately expressed.
Key mitotic regulators such as Bub1, Mad2 and UbcH10 cause aneuploidy and tumour formation when overexpressed in mice [10] [11] [12] . However, T7 and T23 splenocytes and mouse embryonic fibroblasts Spleen  muscle  intestine  WT T7 T23   WT T7 T23 WT T7 T23 WT T7 T23  WT  T7  T23   WT T7 T23 WT T7 T23 WT T7 T23 WT T7 (MEFs) showed normal aneuploidy rates ( Fig. 1d ). Consistent with this, chromosome missegregation rates were not elevated in T7 and T23 MEFs (Fig. 1e ). Transgenic MEFs showed increased BubR1-Cdc20 complex formation ( Supplementary Fig. S1d ), but this had no overt impact on mitotic checkpoint activity ( Fig. 1f ). Key mitotic regulators were expressed at normal levels in T23 MEFs ( Supplementary Fig. S1e ). Tumour susceptibility of T7 and T23 transgenic mice was evaluated using 7,12-dimethylbenz(a)anthracene (DMBA), a carcinogen that causes lung and skin tumours 13 . Only 33% of T23 mice developed tumours in contrast to 100% of wild-type animals ( Fig. 2a ). Reductions in both skin and lung tumour incidence contributed to this decline ( Fig. 2a ). Tumour formation in T7 animals was not significantly reduced. Next, we examined the impact of moderate and high BubR1 overexpression on lung tumour formation in Kras LA1 mice 14 . Kras LA1 mice carry a conditional oncogenic Kras allele (Kras G12D ) that becomes active on intra-chromosomal homologous recombination. At 6 weeks, Kras LA1 mice had on average 17 lung tumours, whereas T23; Kras LA1 mice had only 8 (Fig. 2b) . Again, the moderately expressed T7 transgene failed to reduce tumour formation ( Supplementary Fig. S2a ), indicating that tumour protection requires a threshold of BubR1 overexpression.
Aneuploidy is a hallmark of human cancers, and aneuploidy-prone mouse models indicate that this condition is causally implicated in tumour development [15] [16] [17] . This, combined with the observation that oncogenic Ras promotes chromosome missegregation 18 , led us to propose that BubR1 overexpression suppresses tumorigenesis by counteracting Ras-mediated aneuploidization. To test this notion, we transduced wild-type and T23 MEFs with a retrovirus expressing oncogenic Ras ( Fig. 2c ) and performed chromosome counts on day 5 post-infection. Indeed, BubR1 overexpression markedly decreased Ras-induced aneuploidy (Fig. 2d ), which correlated with reduced chromosome missegregation ( Fig. 2e ). Next, we examined whether increased BubR1 also inhibits aneuploidization in lung tissue of Kras LA1 mice. Acquisition of oncogenic Ras in lung produced a hyperplastic epithelium ( Supplementary Fig. S2b ), which on fluorescence in situ * * hybridization (FISH) analysis for chromosomes 4 and 7 showed increased aneuploidy ( Fig. 2f ). Aneuploidy was significantly reduced in T23; Kras LA1 mice ( Fig. 2f ), but not in T7; Kras LA1 mice ( Supplementary  Fig. S2c ), indicating that protection against tumorigenesis by high levels of BubR1 tightly correlates with reduced aneuploidization.
Ras
To determine how high BubR1 levels counteract aneuploidization we focused on its known roles in mitotic checkpoint control and the establishment of proper microtubule-kinetochore attachments 2, 3, 12, 19 . Mutant MEFs with low amounts of Rae1 have impaired mitotic checkpoint activity and are prone to chromosome segregation errors and aneuploidization 20 . On a T23 background, however, these MEFs had much lower missegregation and aneuploidy rates, which coincided with restoration of normal mitotic checkpoint activity (Fig. 2g,h and Supplementary Fig. S2d ). Bub1 T85 MEFs, which overexpress the mitotic checkpoint protein Bub1, have an intact mitotic checkpoint but are predisposed to chromosome missegregation and aneuploidy due to defective attachment error correction 12 . BubR1 overabundance markedly improved error correction in these MEFs, resulting in decreased aneuploidy ( Fig. 2h and Supplementary Fig. S2d ). Together, these findings indicate that increased BubR1 expression can preserve genomic integrity by ameliorating defects that perturb the mitotic checkpoint and/or kinetochore-microtubule attachment.
To analyse the impact of sustained high BubR1 expression on spontaneous tumorigenesis, we generated a cohort of T23 transgenic mice. As control cohorts, we used non-transgenic littermates and a transgenic strain expressing EGFP under the control of the CAGGS promoter, referred to as T-GFP mice. In accordance with conclusions from the DMBA and Kras LA1 studies, development of lethal tumours (that is, malignant lymphomas, sarcomas and carcinomas) was significantly delayed in T23 mice, revealing a broad tumour protective effect of high BubR1 (Fig. 3a) . The spontaneous tumours that developed in T23 animals contained low amounts of Flag-BubR1 Overall survival curves of wild-type, T-GFP and T23 mice. Note that the maximum lifespan of T23 mice was also significantly extended when compared with both wild-type and T-GFP control mice (P = 0.05 and 0.0056), respectively; one-sided Wang/Allison test referring to the proportion of mice alive at the 90th percentile survival point. Furthermore, note that the median lifespan of our wild-type cohort is similar to that of an earlier, independent study performed at the same site 40 . * P < 0.05, * * P < 0.01, * * * P < 0.001. n indicates the number of mice (mixed gender) per genotype.
( Supplementary Fig. S3a,b ), implying that tumorigenesis selected for loss of transgene expression. Consistent with attenuated tumour development, T23 mice showed increased longevity ( Fig. 3b ). Tumour protection and lifespan extension were observed in both genders, although more profoundly in males ( Supplementary Fig. S3c -f). To explore whether high-level BubR1 expression has anti-ageing effects independent of tumour protection, we analysed T23 and wild-type mice for distinct parameters of healthspan. Muscle loss is a hallmark of ageing in both humans and rodents. In contrast to wild-type mice, which showed a 35% decrease in gastrocnemius muscle fibre diameter between 3 and 24 months of age, T23 mice were protected from muscle fibre atrophy ( Fig. 4a ). Relative gastrocnemius muscle weights of aged T23 mice were significantly larger than those of corresponding control mice ( Supplementary Fig. S4a ). Consistent with reduced muscle degeneration, ageing-induced upregulation of p16 Ink4a and p19 Arf , two biomarkers of senescence and ageing 21 , was blunted in the gastrocnemius of T23 mice (Fig. 4b,c ). T23 mice outperformed wild-type counterparts in treadmill exercise tests ( Fig. 4d-f ), validating preservation of muscle function. Furthermore, renal sclerosis with glomerulosclerosis, interstitial fibrosis and tubular atrophy, which occurs with ageing, was reduced in 24-month-old T23 animals ( Fig. 4g,h ). Blood urea nitrogen levels of these animals were significantly lower than in age-matched wild-type animals (16.10 ± 1.95 mg dl −1 versus 23.02 ± 2.08 mg dl −1 , respectively, P = 0.0136, unpaired t -test), indicating enhanced preservation of renal function. Ageing of kidney is characterized by accumulation of cells with γ-H2AX foci 22, 23 , which are thought to represent senescent cells. The foci themselves represent sites of DNA damage, potentially resulting from aberrant sister chromatid segregation during mitosis 24, 25 . Consistent with reduced age-related pathology, kidneys of 24-month-old T23 animals contained significantly fewer cells with γ-H2AX foci than those of age-matched control mice ( Fig. 4i) . Conversely, the incidence of cells with γ-H2AX foci in kidneys of progeroid BubR1 mice was markedly increased at 3 months of age ( Fig. 4i ), indicating that formation of DNA double-strand breaks (DSBs) inversely correlates with the level of BubR1 expression. Reactive oxygen species (ROS) have been linked to age-related DNA damage 26 , but we found no evidence for alterations in the abundance of or tolerance to ROS in T23 mice ( Supplementary Fig. S4b-d ). Decreased accumulation of cells with γ-H2AX foci in kidney of 24-month-old T23 mice correlated with increased BrdU incorporation, further supporting the idea that elevated BubR1 attenuates senescence-associated replicative arrest ( Supplementary Fig. S4e ).
BubR1 progeroid mice are thought to succumb to early death due to heart failure 27 , prompting us to examine whether sustained BubR1 expression improves cardiac performance. In a cardiac stress tolerance test, in which mice are injected with a lethal dose of the β-adrenergic agonist isoproterenol, wild-type mice suffered cardiac arrest within 6.5 min (Fig. 4j ). Consistent with reduced cardiac stress resistance, 5-month-old BubR1 H / H mice died three times faster than control animals. In contrast, the time to death was significantly extended in T23 animals. Furthermore, whereas cardiac stress tolerance of wild-type mice significantly declined between 5 and 15 months of age, T23 mice retained high cardiac performance. Age-related interstitial fibrosis in heart tissue was markedly lower in T23 mice ( Fig. 4k ), corroborating that BubR1 overexpression acts to preserve cardiac function and structural integrity. Attenuated deterioration of skeletal muscle and heart in T23 mice was not characterized by increased stem cell abundance within these tissues ( Fig. 4l ). T23 animals also showed resistance to age-related retinal atrophy ( Supplementary  Fig. S4f ), which correlated well with increased BubR1 expression in eye ( Supplementary Fig. S1c ). In contrast, osteoporosis and cataractogenesis, two other age-related disorders that we screened for, were not delayed ( Supplementary Fig. S4g -i), indicating that the anti-ageing effect of increased BubR1 expression is confined to particular cell and tissue types.
Aneuploidy increases with ageing in mouse splenocytes 28 . To determine whether age-related aneuplodization also occurs in other tissues and correlates with age-related tissue dysfunction, we performed interphase FISH for chromosomes 4 and 7 on tissues of 3-and 24-month-old wild-type and T23 mice. Aneuploidy rates for both chromosomes markedly increased with ageing in wild-type lung tissue, but not in T23 lungs (Table 1) . Similar data were obtained for tissues that exhibited characteristics of delayed ageing in T23 mice, including skeletal muscle, kidney, eye and heart ( Table 1 ). The presence of age-related aneuploidy in wild-type heart was surprising, given that traditionally heart has been viewed as a terminally differentiated post-mitotic organ. However, recent studies indicate that the heart replaces its cells several times during its lifespan 29 . Inhibition of age-related aneuploidization was not universal as bone marrow and small intestine, two tissues with a relatively high mitotic index, showed similar age-related aneuploidy rates in T23 and wild-type mice (Table 1) . Notably, stem cells in skeletal muscle, heart and bone marrow showed resistance to age-related aneuploidization in both wild-type and T23 animals ( Table 1 ), suggesting that these populations are well protected against whole-chromosome instability. There are several plausible mechanisms for why aneuploidy rates of differentiated cells could be high with stem cell aneuploidy being low ( Supplementary  Fig. S5k ). First, lineage-primed progenitors derived from stem cells undergo multiple rounds of division before differentiation occurs and aneuploidization might occur during this proliferative phase. Second, it is possible that aneuploidy does occur when stem cells divide, but that the daughter cell that inherits stemness dies whereas the progenitor daughter cell survives and continues to proliferate. A third possibility would be that aneuploidization of differentiated cells is due to polyploidy resulting from fusion of nuclei. Polyploid nuclei, however, were not observed or extremely rare in our samples (data not shown).
Finally, age-related aneuploidization and tissue dysfunction were not attenuated in T7 mice ( Supplementary Fig. S5 ), indicating that both beneficial effects require a certain threshold of BubR1 overexpression. Our data here show that sustained high expression of BubR1 in mice protects against cancer, attenuates age-related deterioration of select tissues and extends median and maximum lifespan. We show that these beneficial effects tightly correlate with reduced oncogene-induced or age-related aneuploidization, and that high BubR1 levels act to reinforce mitotic checkpoint control and attachment error correction in the presence of genetic defects that cause mitotic stress. On the basis of these findings, it is tempting to speculate that high-level BubR1 expression extends health-and lifespan by attenuating chromosomal instability. Consistent with this hypothesis, many mouse models of accelerated aneuploidization are prone to tumorigenesis 15, 30, 31 . On the other hand, whereas BubR1 hypomorphic and Bub3/Rae1 double haploinsufficient mice exhibit overt premature ageing phenotypes 1,32 , other aneuploidy-prone mouse strains do not. One possibility is Table 1 Improved healthspan of T23 tissues correlates with reduced aneuploidization with age. that aneuploidy is required, but not sufficient for induction of age-related pathologies. For instance, aneuploidy may contribute to the induction of age-related pathologies only in the presence of other age-associated damage, such as DNA DSBs, mitochondrial DNA damage and proteotoxic damage 33, 34 . Our observation that DSBs, which can result from specific types of chromosome segregation error 26, 27 , were increased in kidney of BubR1 progeroid mice and decreased in kidney of T23 transgenics (Fig. 4i ), supports this notion. Alternatively, the beneficial effects of sustained overexpression of BubR1 could be independent of chromosome segregation. BubR1 is normally present throughout the cell cycle and known to be implicated in roles outside mitosis, including DNA repair and ciliogenesis 35, 36 . Furthermore, recent studies uncovered that APC/C Cdc20 , whose E3 ubiquitin ligase activity is controlled by BubR1, regulates important biological processes in post-mitotic cells such as morphogenesis and differentiation [37] [38] [39] . These findings raise the interesting possibility that BubR1 overexpression might exert its beneficial effects by controlling the stability of interphase APC/C Cdc20 substrates implicated in the suppression of cellular stresses that engage cellular senescence or other ageing-related pathways.
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We provide experimental evidence that overexpression of a mitotic regulator can improve ploidy control, confer resistance to tumorigenesis and delay age-related decline in tissues and organs important to human health in the absence of apparent side effects. These findings identify BubR1 and its regulator(s) as unique and promising targets for treatment of a broad spectrum of aneuploid human cancers and key age-related disorders that dictate health.
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M E T H O D S
METHODS
Generation of Flag-mBubR1 transgenic mice. T7 and T23 BubR1 transgenic
mice overexpressing Flag-tagged murine BubR1 protein were generated according to previously described methods 11, 41 . T-GFP mice, which overexpress EGFP using the same promoter sequence as was used for the BubR1 transgene, were obtained and used as a control (stock number 004178, strain C57BL/6J, Jackson Laboratories). Note that EGFP levels in T-GFP and T23 mice were similar. Protocols used for PCR genotyping of the above strains are available on request. All mice were on a mixed C57BL/6-SV129 background and were housed in a pathogen-free barrier environment for the duration of the study. These animals were fed a 10%-fat diet and maintained on a 12 h light/dark cycle and were inspected daily. Animals in survival curves were mice found dead or euthanized if unlikely to survive for more than 48 h. These mice were carefully screened for tumours. Tumours were collected and processed by standard procedures for histopathological evaluation. Malignant lymphomas, sarcomas and carcinomas were considered in our tumour-free survival analysis. Note that animals used for experiments, including healthspan analyses, were omitted from the survival analysis. For light and fluorescence microscopy imaging of pups and organs we used a fluorescence dissecting microscope mounted with a camera (Leica). All images were taken within an hour of collection from an intra-cardially PBS-flushed mouse. Isoproterenol-challenge assays were performed on male mice. A lethal dose (680 mg kg −1 ) was given to all animals and time until death was measured. All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee.
Statistical analyses.
Prism software was used for the generation of all survival curves and statistical analysis. Log-rank tests were used to determine overall and pairwise significance for all survival curves ( Fig. 3 and Supplementary Fig. S3c-f ). Log-rank tests were also used in Fig. 2g and Supplementary Fig. S4b ,i. One-sided Wang-Allison tests were used to determine maximum lifespan changes 42 in Fig. 3 and Supplementary Fig. S3c-f . Chi-squared tests for overall and pairwise significance were used for overall, lung and skin tumour incidence ( Fig. 2a, first three graphs) . Mann-Whitney tests were used for pairwise significance analysis in the following figures: Fig. 2a (graphs for average number of tumours); Figs 2b,f,h, 4a-c,h-j and Supplementary Figs S2a,c, S4e-h and S5a-c,g-i. Kruskal-Wallis tests for overall significance were performed before conducting these Mann-Whitney tests. An unpaired t -test was used for pairwise comparisons in the following figures: Figs 1d-f, 2d,e, 4d-f,l and Table 1 and Supplementary Figs S2d, S4a,c,d and S5d-f,j.
Western blot analysis, immunoprecipitation and immunohistochemistry.
Immunoprecipitations and western blot analysis were performed as previously described 43 . Mitotic cell lysates were prepared as described previously 3 . Tissue lysates were prepared by first snap-freezing the tissue sample in liquid nitrogen and then grinding it to powder form in mortar and pestle. Ten milligrams of the powder was suspended in 100 µl of 1× PBS and 100 µl of Laemmli lysis buffer and boiled for 10 min before loading into Tris-HCl polyacrylamide gel. Blots were probed with antibodies for P-H3 Ser10 (Millipore; 06-570, 1:500), BubR1 (ref. 1; 1:1,000) Flag (Origene; TA100011, 1:1,000), β-actin (Sigma; A5441, 1:40,000), EGFP (Cell Signaling; 2,956, 1:1,000), Aurora B (BD Biosciences; 611083, 1:1,000), Cdc20 (1:1,000), Plk1 (1:500) and Hras (1:5,000; Santa Cruz Biotechnology; SC-8358, SC-17783 and SC-520, respectively), Bub3 (ref. 20; 1:1,000), Mad2 (ref. 11; 1:1,000) and Bub1 (ref. 44; 1:1,000). All antibodies were detected with secondary HRPconjugated goat anti-mouse or anti-rabbit antibodies (Jackson Immunoresearch; 1:10,000). Equal loading was confirmed by using α-tubulin (Sigma; T9026, 1:2,000) or by Ponceau S staining. Immunohistochemistry for BubR1 (BD Biosciences; 612503, 1:500) was performed on formalin-fixed, paraffin-embedded lung tumour sections using the SignalStain Boost IHC detection reagent as per the manufacturer's instructions (Cell Signaling).
Generation and culture of MEFs and live-cell imaging.
Wild-type, T7 and T23 MEFs were generated and cultured as previously described 1 . Double-mutant MEFs were produced by breeding T23 transgenic females to Rae1 +/− (ref. 20) and Bub1 T85 males 12 . Live-cell imaging-based analyses of chromosome segregation errors and mitotic checkpoint activity were as previously described 11 . Nocodazole-and taxol-challenge assays and mitotic timing experiments were performed as previously described 3 . Oncogenic Ras was expressed in passage 3 (P3) wild-type and T23 MEFs using pBabe puro Hras G12V (Addgene plasmid 9051). Puromycin-resistant MEFs (2 µg ml −1 puromycin) were analysed by live-cell imaging five days posttransduction. At least three independent MEF lines per genotype were used in all experiments.
Karyotype analyses. Splenocyte and MEF karyotype analyses were performed as described previously 20 . FISH analysis on single cells isolated from fresh lung tissue was performed as described previously 6 . Chromosome counts on MEFs expressing oncogenic Ras were done as follows: P3 wild-type and T23 MEFs were transduced with pBabe puro Hras G12V for two days, cultured in medium containing 2 µg ml −1 puromycin for two days and arrested in mitosis with colcemid on day 5. Interphase FISH analysis on cell suspensions prepared from various wild-type, T7 and T23 tissues was performed as previously described 17 in the Mayo Clinic Cytogenetics Core Facility as described in detail in ref. 45 . At least 100 cells were analysed per sample, n ≥ 3 samples per genotype and tissue.
Tumour susceptibility studies. DMBA treatment of mice was performed as previously described 13 . K-ras LA1 mice 14 were obtained from the MMHCC (NCI Frederick).
Age-related phenotyping. Biweekly, mice were screened for overt cataracts 32 .
Muscle fibre diameter measurements were taken on gastrocnemius muscles as previously described 6 . Exercise ability assessments were performed as described previously 27 . Individual gastrocnemius muscles were isolated from 18-month-old female mice. The relative weight is the weight of one gastrocnemius muscle divided by the overall body mass. Bone mineral density and bone mineral content were determined using DEXA (dual-energy X-ray absortiometry) scanning. Formalinfixed, paraffin-embedded kidney samples were stained using routine haematoxylin and eosin staining. Forty randomly selected glomeruli were scored for sclerosis. Glomeruli with >50% sclerosis were determined to be sclerotic. Blood urea nitrogen assays were performed on 24-month-old mice as described previously 46 . Ptah staining on formalin-fixed, paraffin-embedded heart samples was performed as described previously 47 . Retinal thickness was determined by measuring the thickness of the retinal layer in haematoxylin-eosin-stained paraffin-embedded eye tissue using a calibrated computer program (Olympus MicroSuite 5). Forty random measurements were taken for each sample. γ-H2AX staining was performed as described previously 23 .
Stem cell isolation and quantification. Satellite cells were labelled and purified as previously described 48 . Briefly, excised gastrocnemius muscles were washed in PBS and digested in DMEM containing collagenase type II solution (Worthington Biochemical) and 2% FCS for 45-60 min with agitation at 37 • C. Cell suspensions were filtered through a 45 µu mesh and centrifuged for 5 min at 500g . Cells were incubated in blocking buffer for 15 min on ice following antibody staining for CD45, CD34 and Sca1 (all from BD-Biosciences; 557659, 560230 and 553336, respectively). Cells with a CD45 − , Sca-1 − and CD34 + surface profile 49 were collected using a FACS Aria Cell Sorter (BD Biosciences) running FACSDiva software. Enzymatic isolation of endogenous cardiac stem cells was performed after Langendorf perfusion of the heart 50 to obtain a viable single-cell suspension. Following antibody staining for c-Kit, CD45 and CD34, cells with a c-Kit + , CD45 − and CD34 − surface profile were collected 51 (c-Kit antibody was from BD-Biosciences; 561075). Identification and quantification of haematopoietic stem cells was performed as described previously 52 .
Quantitative rtPCR. Quantitative real-time PCR (rtPCR) analysis was performed on complementary DNA generated from RNA extracted from gastrocnemius muscle of 3-month-old and 24-month-old mice as previously described 6 .
In vivo BrdU incorporation. Analyses for in vivo BrdU incorporation were performed on 24-month-old mice as previously described 6 .
Assessment of ROS resistance by paraquat. Paraquat (methyl viologen; Sigma)
was dissolved in sterile saline and administered to 3-to 4-month-old mice by intraperitoneal injection at a dose of 60 mg kg −1 body weight. Animals were monitored for survival for 10 days following paraquat injection.
Hydrogen peroxide and DCFDA assay. Hydrogen peroxide (H 2 O 2 ) levels in gastrocnemius muscle of 24-month-old mice were determined by using the Amplex Red Hydrogen Peroxide Assay Kit according to the protocol of the manufacturer (Invitrogen). Fluorescence signal was measured using an excitation wavelength of 545 nm and an emission wavelength of 590 nm. The H 2 O 2 concentration per milligram of protein was calculated by using a standard curve. H 2 O 2 levels were presented as relative to 24-month-old wild-type mice. ROS levels in liver of 24-month-old mice were analysed by using carboxy-DCFDA (2 ,7dichlorodihydrofluorescein diacetate, Invitrogen). Tissue extracts were added DOI: 10.1038/ncb2643 to DCFDA (25 µM) and fluorescence signal was measured using an excitation wavelength of 485 nm and an emission wavelength of 530 nm. For both experiments, the homogenization buffer consisted of 20 mM glycerolphosphate, 20 mM NaF, 2 mM sodium orthovanadate, 1 mM EDTA, 0.5 mM phenylmethyl sulphonyl fluoride, 1 µM pepstatin, 100 mM Tris-HCl (pH 7.4) and a freshly added mini EDTA-free cocktail tablet (Roche). 
